Beranda › Kanker Paru Non-Sel Kecil › Minnesota › Saint Paul
Uji klinis Kanker Paru Non-Sel Kecil di Saint Paul, MN
19 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Saint Paul (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Menerima pesertaFase 3
- United Hospital, Saint Paul
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Regions Hospital, Saint Paul
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi jauhnya
- Minnesota Oncology Hematology, PA, Woodbury · 7 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi jauhnya
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi jauhnya
- dan 1 lainnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Regions Hospital, Saint Paul
- M Health Fairview St. John's Hospital, Maplewood · 5 mi jauhnya
- Minnesota Oncology Hematology PA, Maplewood · 5 mi jauhnya
- dan 1 lainnya
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Menerima pesertaFase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi jauhnya
- dan 3 lainnya
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Menerima pesertaFase 3
- Clinical Study Site, Saint Paul
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- HealthPartners Cancer Research Center, Saint Paul
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Research Site, Saint Paul
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- USOR Minnesota Oncology Hematology, Maplewood · 5 mi jauhnya
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Menerima pesertaFase 1/2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Menerima pesertaFase 1/2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Allina Health Cancer Institute, Saint Paul
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Woodbury, Woodbury · 7 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi jauhnya
- dan 3 lainnya
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Research Site 121, Saint Paul
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Saint Paul
- Kanker Prostat13 studi
- Kanker Paru13 studi
- Kanker Payudara12 studi
- Kanker Kolorektal9 studi
- Kanker Ovarium8 studi
- Kanker Metastatik7 studi
- Kanker Ginjal (Karsinoma Sel Renal)7 studi
- Kanker Endometrium6 studi
- Kanker Kandung Kemih6 studi
- Melanoma6 studi
- Karsinoma Sel Skuamosa Kepala dan Leher6 studi
- Leukemia Mieloid Akut6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.